Skip to main content
. 2021 Mar 25;38(3):375–386. doi: 10.1007/s10719-021-09992-w

Table 1.

Clinical characteristics of patients included in the study

(Likely) damaging allele
n = 18 cases
VUS
n = 5 cases
(Likely) benign
n = 8 cases
No rare HNF1A allele variant
n = 289 cases
Sex, male:female [%] 28:72 40:60 50:50 52:48
Age at recruitment [years] 39.7 (17.4) 54.2 (14.2) 48.1 (11.2) 45.6 (9.7)
Age at diagnosis [years] 25.7 (8.6) 37.3 (9.8) 36.4 (5.6) 35.3 (6.5)
Diabetes duration [years] 13.1 (11.6) 17.3 (10.6) 9.1 (6.6) 10.3 (7.7)
BMI [kg/m2] 25.93 (4.75) 28.34 (6.19) 34.61 (5.02) 29.95 (5.76)
hsCRP [mg/L] 0.80 (1.32) 4.01 (6.30) 5.21 (5.75) 3.79 (6.97)
HbA1c [%] 7.7 (1.7) 6.7 (1.3) 8.8 (2.1) 7.6 (1.8)
C-peptide [nmol/L] 0.42 (0.21) 0.60 (0.57) 0.81 (0.62) 0.75 (0.36)
Total cholesterol [mmol/L] 4.75 (1.09) 4.74 (1.21) 5.07 (0.88) 4.79 (1.36)
HDL [mmol/L] 1.37 (0.32) 1.28 (0.39) 1.11 (0.23) 1.17 (0.36)
Triglycerides [mmol/L] 1.24 (0.51) 1.12 (0.31) 1.98 (0.96) 2.15 (1.98)

Mean values are presented for each group (standards deviation (SD) in parentheses)